• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病-矿物质和骨异常(CKD-MBD)表型对维持性血液透析患者健康相关生活质量的影响:一项横断面研究。

Effect of CKD-MBD phenotype on health-related quality of life in patients receiving maintenance hemodialysis: A cross-sectional study.

作者信息

Luo Laimin, Chen Qinkai

机构信息

Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, P.R. China.

出版信息

J Int Med Res. 2020 Feb;48(2):300060519895844. doi: 10.1177/0300060519895844.

DOI:10.1177/0300060519895844
PMID:32054360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7105727/
Abstract

OBJECTIVE

This study aimed to investigate the factors influencing health-related quality of life (HRQoL) in patients with different chronic kidney disease–mineral and bone disorder (CKD–MBD) phenotypes.

METHODS

Patients undergoing maintenance hemodialysis (MHD) at our center from 1 July to 31 August 2017 were enrolled. Patients who received hemodialysis for less than 3 months or displayed poor compliance, or those with incomplete clinical data were excluded. QoL was evaluated using the Kidney Disease Quality of Life–Short Form (KDQOL-SF™) 1.3 scale. The influential factors were stratified based on different CKB–MBD phenotypes.

RESULTS

There were 296 patients enrolled. The serum intact parathyroid hormone (iPTH) concentration was 436.40 ± 490.99 pg/mL, serum calcium (Ca) concentration was 2.14 ±0.27 mmol/L, serum phosphorus (P) concentration was 1.81 ± 0.56 mmol/L, the kidney disease and dialysis-related QoL (KDTA) score was 57.07 ± 10.40, and the SF-36 score was 51.45 ± 17.62. Among patients with different CKD–MBD phenotypes, HRQoL was highest in the group with an iPTH concentration of 150 to 300 pg/mL, serum Ca concentration of <2.10 mmol/L, and serum P concentration of >1.78 mmol/L.

CONCLUSIONS

CKD−MBD phenotypes significantly affected HRQoL. Comprehensive management of serum iPTH, Ca, and P levels is important to improve QoL in patients receiving hemodialysis.

摘要

目的

本研究旨在调查影响不同慢性肾脏病-矿物质和骨异常(CKD-MBD)表型患者健康相关生活质量(HRQoL)的因素。

方法

纳入2017年7月1日至8月31日在本中心接受维持性血液透析(MHD)的患者。排除透析时间少于3个月、依从性差或临床资料不完整的患者。使用肾脏病生活质量简表(KDQOL-SF™)1.3量表评估生活质量。根据不同的CKB-MBD表型对影响因素进行分层。

结果

共纳入296例患者。血清全段甲状旁腺激素(iPTH)浓度为436.40±490.99 pg/mL,血清钙(Ca)浓度为2.14±0.27 mmol/L,血清磷(P)浓度为1.81±0.56 mmol/L,肾脏病及透析相关生活质量(KDTA)评分为57.07±10.40,SF-36评分为51.45±17.62。在不同CKD-MBD表型的患者中,iPTH浓度为150至300 pg/mL、血清Ca浓度<2.10 mmol/L且血清P浓度>1.78 mmol/L的组HRQoL最高。

结论

CKD-MBD表型显著影响HRQoL。全面管理血清iPTH、Ca和P水平对于改善血液透析患者的生活质量很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/d6793290acf4/10.1177_0300060519895844-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/4c11aafb0fd1/10.1177_0300060519895844-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/3752387a886c/10.1177_0300060519895844-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/d66e4e9a5709/10.1177_0300060519895844-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/942e6d8c37ef/10.1177_0300060519895844-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/2aff0d144f6a/10.1177_0300060519895844-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/55d5e220dba7/10.1177_0300060519895844-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/d6793290acf4/10.1177_0300060519895844-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/4c11aafb0fd1/10.1177_0300060519895844-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/3752387a886c/10.1177_0300060519895844-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/d66e4e9a5709/10.1177_0300060519895844-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/942e6d8c37ef/10.1177_0300060519895844-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/2aff0d144f6a/10.1177_0300060519895844-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/55d5e220dba7/10.1177_0300060519895844-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a95/7105727/d6793290acf4/10.1177_0300060519895844-fig7.jpg

相似文献

1
Effect of CKD-MBD phenotype on health-related quality of life in patients receiving maintenance hemodialysis: A cross-sectional study.慢性肾脏病-矿物质和骨异常(CKD-MBD)表型对维持性血液透析患者健康相关生活质量的影响:一项横断面研究。
J Int Med Res. 2020 Feb;48(2):300060519895844. doi: 10.1177/0300060519895844.
2
[Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].透析阶段前骨与矿物质代谢紊乱的管理仍有完善空间。来自法国磷与钙调查(Photo-Graphe)的数据
Nephrol Ther. 2017 Nov;13(6):470-478. doi: 10.1016/j.nephro.2017.02.009. Epub 2017 Aug 23.
3
Secondary hyperparathyroidism among Nigerians with chronic kidney disease.尼日利亚慢性肾脏病患者中的继发性甲状旁腺功能亢进
Afr Health Sci. 2018 Jun;18(2):446-457. doi: 10.4314/ahs.v18i2.30.
4
The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.慢性肾脏病-矿物质和骨异常在慢性肾脏病各阶段的复杂性。
Kidney Int. 2017 Jun;91(6):1436-1446. doi: 10.1016/j.kint.2016.12.029. Epub 2017 Mar 18.
5
Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study.藏高原血液透析患者的矿物质和骨代谢紊乱:一项多中心横断面研究。
Ren Fail. 2019 Nov;41(1):636-643. doi: 10.1080/0886022X.2019.1635892.
6
Prevalence and pattern of chronic kidney disease-mineral bone disorders among hemodialysis patients in kano, northwest nigeria.尼日利亚西北部卡诺地区血液透析患者慢性肾脏病-矿物质和骨异常的患病率及模式
Ann Afr Med. 2019 Oct-Dec;18(4):191-195. doi: 10.4103/aam.aam_18_19.
7
Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.CKD 患者的骨折:欧洲钙化组织协会和欧洲肾脏协会肾脏病透析与移植分会成员的综述
Kidney Int. 2017 Dec;92(6):1343-1355. doi: 10.1016/j.kint.2017.07.021. Epub 2017 Sep 28.
8
Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population.透析人群慢性肾脏病矿物质和骨异常的表型。
Arch Med Res. 2024 Jun;55(4):103008. doi: 10.1016/j.arcmed.2024.103008. Epub 2024 Jun 1.
9
Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.新发病血液透析患者矿物质与骨代谢紊乱标志物及死亡率的变化
Am J Nephrol. 2016;43(2):85-96. doi: 10.1159/000444890. Epub 2016 Mar 8.
10
CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.血液透析患者的慢性肾脏病-矿物质和骨异常与死亡和心血管住院风险。
Clin J Am Soc Nephrol. 2013 Dec;8(12):2132-40. doi: 10.2215/CJN.04260413. Epub 2013 Sep 19.

引用本文的文献

1
Efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate: A systematic review and meta-analysis.羟基氧化铁蔗糖与碳酸司维拉姆的疗效和安全性:一项系统评价与荟萃分析。
Hemodial Int. 2025 Jan;29(1):6-16. doi: 10.1111/hdi.13187. Epub 2024 Oct 18.
2
New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province.新的 CKD-MBD 三联治疗诊断方法:山西省的一项横断面研究。
BMJ Open. 2024 Aug 17;14(8):e081485. doi: 10.1136/bmjopen-2023-081485.
3
Longitudinal Assessment of Health-Related Quality of Life in Three Different Hyperphosphatemia Management Groups of Stage III and IV Chronic Kidney Disease Patients.

本文引用的文献

1
Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China.中国四川省血液透析患者的流行病学调查与分析。
Ren Fail. 2019 Nov;41(1):644-649. doi: 10.1080/0886022X.2019.1612429.
2
Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study.终末期肾病患者健康相关生活质量作为死亡率预测指标的观察性研究
BMC Nephrol. 2019 Apr 29;20(1):144. doi: 10.1186/s12882-019-1318-x.
3
Correlation between Aortic Calcification Score and Biochemical Parameters in Hemodialysis Patients.
III期和IV期慢性肾病患者三种不同高磷血症管理组健康相关生活质量的纵向评估
Indian J Nephrol. 2024 Mar-Apr;34(2):119-128. doi: 10.4103/ijn.ijn_6_23. Epub 2023 Sep 29.
4
Overview of renal osteodystrophy in Brazil: a cross-sectional study.巴西肾性骨营养不良概述:一项横断面研究。
J Bras Nefrol. 2023 Apr-Jun;45(2):257-261. doi: 10.1590/2175-8239-JBN-2022-0146en.
5
The Effect of Humanistic Care Combined with Predictive Nursing on Negative Emotions and Incidence of Cardiovascular Events in Hemodialysis Patients.人文关怀联合预见性护理对血液透析患者负面情绪及心血管事件发生率的影响。
Comput Math Methods Med. 2022 Apr 29;2022:7562525. doi: 10.1155/2022/7562525. eCollection 2022.
6
Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.柠檬酸铁和静脉注射蔗糖铁对 CKD-MBD 大鼠模型中矿物质、骨骼和铁稳态标志物的影响。
Nephrol Dial Transplant. 2022 Sep 22;37(10):1857-1867. doi: 10.1093/ndt/gfac162.
7
Influence of continuity of care on self-management ability and quality of life in outpatient maintenance hemodialysis patients.连续性护理对门诊维持性血液透析患者自我管理能力和生活质量的影响。
Ther Apher Dial. 2022 Dec;26(6):1166-1173. doi: 10.1111/1744-9987.13800. Epub 2022 Feb 11.
血液透析患者主动脉钙化评分与生化参数的相关性
Contrib Nephrol. 2019;198:40-51. doi: 10.1159/000496717. Epub 2019 Apr 16.
4
Calcium phosphate product level as a predictor for arteriovenous fistula re-operations in patients with chronic renal failure.磷酸钙产物水平作为慢性肾衰竭患者动静脉内瘘再次手术的预测指标。
Vascular. 2019 Jun;27(3):284-290. doi: 10.1177/1708538118814611. Epub 2018 Nov 21.
5
Admission serum phosphate levels predict hospital mortality.入院时血清磷酸盐水平可预测医院死亡率。
Hosp Pract (1995). 2018 Aug;46(3):121-127. doi: 10.1080/21548331.2018.1483172. Epub 2018 Jun 18.
6
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.慢性肾脏病-矿物质和骨异常的诊断、评估、预防和治疗:肾脏病改善全球结局组织 2017 年临床实践指南更新概要。
Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640. Epub 2018 Feb 20.
7
Comparison of Quality of Life in Patients Undergoing Hemodialysis and Peritoneal Dialysis: a Systematic Review and Meta-Analysis.血液透析与腹膜透析患者生活质量的比较:一项系统评价与Meta分析
Kidney Blood Press Res. 2017;42(4):717-727. doi: 10.1159/000484115. Epub 2017 Oct 19.
8
Health-related quality of life of patients on chronic dialysis: The need for a focused effort.慢性透析患者的健康相关生活质量:需要集中精力关注。
Semin Dial. 2017 Sep;30(5):413-416. doi: 10.1111/sdi.12620. Epub 2017 Jun 13.
9
Parathyroid hormone metabolism and signaling in health and chronic kidney disease.甲状旁腺激素代谢和信号转导在健康和慢性肾脏病中的作用。
Kidney Int. 2016 Dec;90(6):1184-1190. doi: 10.1016/j.kint.2016.06.041. Epub 2016 Sep 18.
10
Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients.亚洲透析前患者贫血及矿物质与骨代谢异常与健康相关生活质量的关联
Health Qual Life Outcomes. 2016 Jun 24;14:94. doi: 10.1186/s12955-016-0477-8.